195 related articles for article (PubMed ID: 35258170)
1. Progranulin mutations in clinical and neuropathological Alzheimer's disease.
Vardarajan BN; Reyes-Dumeyer D; Piriz AL; Lantigua RA; Medrano M; Rivera D; Jiménez-Velázquez IZ; Martin E; Pericak-Vance MA; Bush W; Farrer L; Haines JL; Wang LS; Leung YY; Schellenberg G; Kukull W; De Jager P; Bennett DA; Schneider JA; ; Mayeux R
Alzheimers Dement; 2022 Dec; 18(12):2458-2467. PubMed ID: 35258170
[TBL] [Abstract][Full Text] [Related]
2. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
3. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.
Redaelli V; Rossi G; Maderna E; Kovacs GG; Piccoli E; Caroppo P; Cacciatore F; Spinello S; Grisoli M; Sozzi G; Salmaggi A; Tagliavini F; Giaccone G
Brain Pathol; 2018 Jan; 28(1):72-76. PubMed ID: 27997711
[TBL] [Abstract][Full Text] [Related]
5. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
[TBL] [Abstract][Full Text] [Related]
7. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
[TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
Chen-Plotkin AS; Martinez-Lage M; Sleiman PM; Hu W; Greene R; Wood EM; Bing S; Grossman M; Schellenberg GD; Hatanpaa KJ; Weiner MF; White CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach TG; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Pickering-Brown SM; Snowden J; van Swieten JC; Heutink P; Seelaar H; Murrell JR; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio E; Lladó A; Miller BL; Alzualde A; Moreno F; Rohrer JD; Mackenzie IR; Feldman HH; Hamilton RL; Cruts M; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bird TD; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van Deerlin VM
Arch Neurol; 2011 Apr; 68(4):488-97. PubMed ID: 21482928
[TBL] [Abstract][Full Text] [Related]
10. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
[TBL] [Abstract][Full Text] [Related]
11. Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family.
Sieben A; Van Mossevelde S; Wauters E; Engelborghs S; van der Zee J; Van Langenhove T; Santens P; Praet M; Boon P; Miatton M; Van Hoecke S; Vandenbulcke M; Vandenberghe R; Cras P; Cruts M; De Deyn PP; Van Broeckhoven C; Martin JJ
Alzheimers Res Ther; 2018 Jan; 10(1):7. PubMed ID: 29370838
[TBL] [Abstract][Full Text] [Related]
12. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.
Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L
J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
[TBL] [Abstract][Full Text] [Related]
14. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.
Dickson DW; Baker M; Rademakers R
Neurodegener Dis; 2010; 7(1-3):170-4. PubMed ID: 20197700
[TBL] [Abstract][Full Text] [Related]
15. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
[TBL] [Abstract][Full Text] [Related]
16. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
[TBL] [Abstract][Full Text] [Related]
17. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Carter D; Cairns NJ
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
[TBL] [Abstract][Full Text] [Related]
18. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
[TBL] [Abstract][Full Text] [Related]
19. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases.
Bit-Ivan EN; Suh E; Shim HS; Weintraub S; Hyman BT; Arnold SE; McCarty-Wood E; Van Deerlin VM; Schneider JA; Trojanowski JQ; Frosch MP; Baker MC; Rademakers R; Mesulam M; Bigio EH
J Neuropathol Exp Neurol; 2014 May; 73(5):467-73. PubMed ID: 24709683
[TBL] [Abstract][Full Text] [Related]
20. Progranulin and TDP-43: mechanistic links and future directions.
Kumar-Singh S
J Mol Neurosci; 2011 Nov; 45(3):561-73. PubMed ID: 21863317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
